Lv1
50 积分 2024-09-27 加入
Antibody drug conjugates: The dos and don'ts in clinical development
8天前
已完结
Splicing Inhibitors as Antibody–Drug Conjugate (ADC) Payloads
1个月前
已完结
ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers
2个月前
已完结
Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists
2个月前
已完结
Efficiency of bis-amidate phosphonate prodrugs
2个月前
已完结
Arnicolide D Inhibits Oxidative Stress-Induced Breast Cancer Cell Growth And Invasion Through Apoptosis, Ferroptosis, And Parthanatos
2个月前
已完结
Parthanatos and its associated components: Promising therapeutic targets for cancer
2个月前
已完结
Parthanatos and its associated components: Promising therapeutic targets for cancer
2个月前
已完结
Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
3个月前
已完结
PRLX 93936, a novel, small molecule with broad antitumor activity in vitro
3个月前
已关闭
皖公网安备34019202002308
